Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.
Summary
Bill A06518 aims to amend the public health law in New York by mandating that both prescribing practitioners and pharmacists counsel patients about the addictive properties of opioids. This requirement applies to patients who are either initiating or continuing opioid treatment for pain. The counseling must occur at the time of the initial prescription and at each renewal, and it should cover risks of dependence, misuse, overdose, pain management, side effects, treatment goals, and the use of naloxone for overdose situations. Exceptions to this requirement are made for patients undergoing cancer treatment, hospice care, post-surgery treatment, or in medical emergencies.
Impact
If enacted, this bill would significantly alter the process by which opioids are prescribed and dispensed in New York. It would create a new legal obligation for healthcare providers to inform patients and their families about the risks associated with opioid use, potentially leading to increased awareness and education around opioid addiction. This could also impact the way healthcare providers approach pain management and opioid prescriptions, encouraging more cautious prescribing practices and possibly reducing opioid misuse and dependency rates.
Sentiment
The sentiment surrounding Bill A06518 appears to be generally supportive, as it addresses a critical public health issue concerning opioid addiction. However, there may be some concerns regarding the additional responsibilities placed on healthcare providers and the potential for increased administrative burdens. Discussions in committee may reflect a balance between the need for patient education and the practicality of implementing these counseling requirements.
Contention
Notable points of contention may arise around the exceptions provided in the bill, particularly regarding the treatment of patients in hospice care or those undergoing cancer treatment. Some stakeholders may argue that these exceptions could undermine the bill's intent to ensure comprehensive counseling for all patients prescribed opioids. Additionally, there may be differing opinions on the effectiveness of counseling as a means to combat opioid addiction, with some advocating for more stringent measures.
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven-day supply, except in certain circumstances.
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.
Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.
Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.